Suppr超能文献

丙型肝炎病毒在受感染的人类肝细胞中诱导端粒酶逆转录酶表达,增加其催化活性,并促进半胱天冬酶降解。

HCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human Hepatocytes.

作者信息

Zhu Zhaowen, Tran Huy, Mathahs M Meleah, Moninger Thomas O, Schmidt Warren N

机构信息

Department of Internal Medicine and Research Service, Veterans Affairs Medical Center, Iowa City, IA, United States of America.

Department of Internal Medicine Roy G. and Lucille A. Carver College of Medicine, University of Iowa Iowa City, IA, United States of America.

出版信息

PLoS One. 2017 Jan 5;12(1):e0166853. doi: 10.1371/journal.pone.0166853. eCollection 2017.

Abstract

INTRODUCTION

Telomerase repairs the telomeric ends of chromosomes and is active in nearly all malignant cells. Hepatitis C virus (HCV) is known to be oncogenic and potential interactions with the telomerase system require further study. We determined the effects of HCV infection on human telomerase reverse transcriptase (TERT) expression and enzyme activity in primary human hepatocytes and continuous cell lines.

RESULTS

Primary human hepatocytes and Huh-7.5 hepatoma cells showed early de novo TERT protein expression 2-4 days after infection and these events coincided with increased TERT promoter activation, TERT mRNA, and telomerase activity. Immunoprecipitation studies demonstrated that NS3-4A protease-helicase, in contrast to core or NS5A, specifically bound to the C-terminal region of TERT through interactions between helicase domain 2 and protease sequences. Increased telomerase activity was noted when NS3-4A was transfected into cells, when added to reconstituted mixtures of TERT and telomerase RNA, and when incubated with high molecular weight telomerase 'holoenzyme' complexes. The NS3-4A catalytic effect on telomerase was inhibited with primuline or danoprevir, agents that are known to inhibit NS3 helicase and protease activities respectively. In HCV infected cells, NS3-4A could be specifically recovered with telomerase holoenzyme complexes in contrast to NS5A or core protein. HCV infection also activated the effector caspase 7 which is known to target TERT. Activation coincided with the appearance of lower molecular weight carboxy-terminal fragment(s) of TERT, chiefly sized at 45 kD, which could be inhibited with pancaspase or caspase 7 inhibitors.

CONCLUSIONS

HCV infection induces TERT expression and stimulates telomerase activity in addition to triggering Caspase activity that leads to increased TERT degradation. These activities suggest multiple points whereby the virus can influence neoplasia. The NS3-4A protease-helicase can directly bind to TERT, increase telomerase activity, and thus potentially influence telomere repair and host cell neoplastic behavior.

摘要

引言

端粒酶可修复染色体的端粒末端,且在几乎所有恶性细胞中均有活性。丙型肝炎病毒(HCV)具有致癌性,其与端粒酶系统的潜在相互作用有待进一步研究。我们测定了HCV感染对原代人肝细胞和连续细胞系中人类端粒酶逆转录酶(TERT)表达及酶活性的影响。

结果

原代人肝细胞和Huh-7.5肝癌细胞在感染后2 - 4天出现早期TERT蛋白的从头表达,这些事件与TERT启动子激活增加、TERT mRNA及端粒酶活性升高相一致。免疫沉淀研究表明,与核心蛋白或NS5A不同,NS3 - 4A蛋白酶 - 解旋酶通过解旋酶结构域2与蛋白酶序列之间的相互作用,特异性地结合到TERT的C末端区域。当NS3 - 4A转染到细胞中、添加到TERT和端粒酶RNA的重组混合物中以及与高分子量端粒酶“全酶”复合物一起孵育时,端粒酶活性均增加。用已知分别抑制NS3解旋酶和蛋白酶活性的普律米灵或达诺普韦可抑制NS3 - 4A对端粒酶的催化作用。在HCV感染的细胞中,与NS5A或核心蛋白不同,NS3 - 4A可与端粒酶全酶复合物特异性地共沉淀。HCV感染还激活了已知靶向TERT的效应半胱天冬酶7。激活与TERT较低分子量的羧基末端片段(主要大小为45 kD)的出现同时发生,用泛半胱天冬酶或半胱天冬酶7抑制剂可抑制这些片段的出现。

结论

HCV感染除了触发导致TERT降解增加的半胱天冬酶活性外,还诱导TERT表达并刺激端粒酶活性。这些活性提示病毒可通过多个环节影响肿瘤形成。NS3 - 4A蛋白酶 - 解旋酶可直接结合TERT,增加端粒酶活性,从而可能影响端粒修复和宿主细胞的肿瘤行为。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验